{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:38:27Z","timestamp":1791607107711,"version":"4.3.4"},"reference-count":54,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The aim of this study is to fabricate reactive oxygen species (ROS)-sensitive nanoparticles composed of succinyl \u03b2-cyclodextrin (bCDsu), memantine and thioketal linkages for application in Alzheimer\u2019s disease, and to investigate the suppression of N-methyl-d-aspartate (NMDA) receptor 1 (NMDAR1) in cells. Thioketal diamine was attached to the carboxyl group of bCDsu to produce thioketal-decorated bCDsu conjugates (bCDsu-thioketal conjugates) and memantine was conjugated with thioketal dicarboxylic acid (memantine-thioketal carboxylic acid conjugates). Memantine-thioketal carboxylic acid conjugates were attached to bCDsu-thioketal conjugates to produce bCDsu-thioketal-memantine (bCDsuMema) conjugates. SH-SY5Y neuroblastoma cells and U87MG cells were used for NMDAR1 protein expression and cellular oxidative stress. Nanoparticles of bCDsuMema conjugates were prepared by means of a dialysis procedure. Nanoparticles of bCDsuMema conjugates had small particle sizes less than 100 nm and their morphology was found to be spherical in transmission electron microscopy observations (TEM). Nanoparticles of bCDsuMema conjugates responded to H2O2 and disintegrated or swelled in aqueous solution. Then, the nanoparticles rapidly released memantine according to the concentration of H2O2. In an in vivo animal imaging study, thioketal-decorated nanoparticles labelled with fluorescent dye such as chlorin e6 (Ce6) showed that the fluorescence intensity was stronger in the brain than in other organs, indicating that bCDsuMema nanoparticles can efficiently target the brain. When cells were exposed to H2O2, the viability of cells was time-dependently decreased. Memantine or bCDsuMema nanoparticles did not practically affect the viability of the cells. Furthermore, a western blot assay showed that the oxidative stress produced in cells using H2O2 increased the expression of NMDAR1 protein in both SH-SY5Y and U87MG cells. Memantine or bCDsuMema nanoparticles efficiently suppressed the NMDAR1 protein, which is deeply associated with Alzheimer\u2019s disease. Fluorescence microscopy also showed that H2O2 treatment induced green fluorescence intensity, which represents intracellular ROS levels. Furthermore, H2O2 treatment increased the red fluorescence intensity, which represents the NMDAR1 protein, i.e., oxidative stress increases the expression of NMDAR1 protein level in both SH-SY5Y and U87MG cells. When memantine or bCDsuMema nanoparticles were treated in cells, the oxidative stress-mediated expression of NMDAR1 protein in cells was significantly decreased, indicating that bCDsuMema nanoparticles have the capacity to suppress NMDAR1 expression in brain cells, which has relevance in terms of applications in Alzheimer\u2019s disease.<\/jats:p>","DOI":"10.3390\/ijms222212309","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T08:19:20Z","timestamp":1636964360000},"page":"12309","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of N-Methyl-d-aspartate Receptor Subunit 1 in Brain Cancer Cells for Alzheimer\u2019s Disease Application"],"prefix":"10.3390","volume":"22","author":[{"given":"Jung Sun","family":"Park","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School, 42 Jebongro, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeyeon","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Art&Science, University of Pennsylvania, 249 S 36th St., Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dohoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-IL","family":"Jeong","sequence":"additional","affiliation":[{"name":"Research Institute of Convergence of Biomedical Sciences, Pusan National University Yangsan Hospital, Yangsan 50612, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1515\/hsz-2013-0241","article-title":"The role of oxidative stress during inflammatory processes","volume":"395","author":"Lugrin","year":"2014","journal-title":"Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"102089","DOI":"10.1016\/j.redox.2021.102089","article-title":"Role of acetylation in doxorubicin-induced cardiotoxicity","volume":"46","author":"Li","year":"2021","journal-title":"Redox Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/4846951","article-title":"The Relationship between Serum Trace Elements and Oxidative Stress of Patients with Different Types of Cancer","volume":"2021","author":"Yang","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8609213","article-title":"Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus","volume":"2020","author":"Yaribeygi","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sun, Y., Rawish, E., Nording, H., and Langer, H. (2021). Inflammation in Metabolic and Cardiovascular Disorders\u2014Role of Oxidative Stress. Life, 11.","DOI":"10.3390\/life11070672"},{"key":"ref_7","first-page":"1","article-title":"Autophagy and Redox Homeostasis in Parkinson\u2019s: A Crucial Balancing Act","volume":"2020","author":"Lane","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/504678","article-title":"The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer\u2019s Disease and Vascular Dementia","volume":"2015","author":"Luca","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_9","first-page":"376","article-title":"Oxidative stress in neurodegenerative diseases","volume":"7","author":"Chen","year":"2012","journal-title":"Neural Regen. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081583"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI200318182","article-title":"Oxidative stress, cell cycle, and neurodegeneration","volume":"111","author":"Klein","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tejchman, K., Kotfis, K., and Sie\u0144ko, J. (2021). Biomarkers and Mechanisms of Oxidative Stress\u2014Last 20 Years of Research with an Emphasis on Kidney Damage and Renal Transplantation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158010"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.freeradbiomed.2009.07.034","article-title":"Oxidative stress upregulates the NMDA receptor on cerebrovascular endothelium","volume":"47","author":"Betzen","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2105607","article-title":"Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View","volume":"2019","author":"Cenini","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.9758\/cpn.2021.19.3.423","article-title":"Novel biomarkers of Alzheimer\u2019s disease: Based upon N-methyl-d-aspartate receptor hypoactivation and oxidative stress","volume":"19","author":"Chiang","year":"2021","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/10715762.2017.1315114","article-title":"In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer\u2019s disease, Parkinson\u2019s disease, and diabetes","volume":"51","author":"Umeno","year":"2017","journal-title":"Free Radic. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/427318","article-title":"Oxidative Stress in Alzheimer\u2019s Disease: Why Did Antioxidant Therapy Fail?","volume":"2014","author":"Persson","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","article-title":"Management of oxidative stress and other pathologies in Alzheimer\u2019s disease","volume":"93","author":"Simunkova","year":"2019","journal-title":"Arch. Toxicol."},{"key":"ref_19","first-page":"259","article-title":"Therapeutic agents for Alzheimer\u2019s disease","volume":"5","author":"Suh","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yu, T.-W., Lane, H.-Y., and Lin, C.-H. (2021). Novel Therapeutic Approaches for Alzheimer\u2019s Disease: An Updated Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158208"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cruz-Vicente, P., Passarinha, L., Silvestre, S., and Gallardo, E. (2021). Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. Molecules, 26.","DOI":"10.3390\/molecules26082193"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of oxidative stress and synapse dys-function in the pathogenesis of Alzheimer\u2019s disease: Understanding the therapeutics strategies","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3389\/fphar.2020.538095","article-title":"Frequency and Severity of Adverse Drug Reactions to Medications Prescribed for Alzheimer\u2019s Disease in a Brazilian City: Cross-Sectional Study","volume":"11","author":"Ferreira","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/head.14186","article-title":"Role of memantine in the prophylactic treatment of episodic migraine: A systematic review","volume":"61","author":"Mistry","year":"2021","journal-title":"Headache J. Head Face Pain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.addr.2011.12.005","article-title":"Drug delivery to the brain in Alzheimer\u2019s disease: Consideration of the blood-brain barrier","volume":"64","author":"Banks","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1124\/dmd.110.033324","article-title":"Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer\u2019s disease-related animal models despite reported blood-brain barrier disruption","volume":"38","author":"Cheng","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"ref_27","first-page":"1114","article-title":"Nanoparticles: A Hope for the Treatment of Inflammation in CNS","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s13534-021-00198-5","article-title":"Recent advances with liposomes as drug carriers for treatment of neurodegenerative diseases","volume":"11","author":"Seo","year":"2021","journal-title":"Biomed. Eng. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105008","DOI":"10.1016\/j.neuint.2021.105008","article-title":"Biomaterials in treatment of Alzheimer\u2019s disease","volume":"145","author":"Agrawal","year":"2021","journal-title":"Neurochem. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.msec.2017.12.029","article-title":"Targeted transport of nanocarriers into brain for theranosis with rabies virus glycoprotein-derived peptide","volume":"87","author":"Fu","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsps.2011.04.001","article-title":"Nanoparticles: Emerging carriers for drug delivery","volume":"19","author":"Mudshinge","year":"2011","journal-title":"Saudi Pharm. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"612692","DOI":"10.3389\/fphar.2021.612692","article-title":"Nano-Neurotheranostics: Impact of Nanoparticles on Neural Dysfunctions and Strategies to Reduce Toxicity for Improved Efficacy","volume":"12","author":"Vinod","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/1061186X.2016.1184272","article-title":"Nano carriers for drug transport across the blood\u2013brain barrier","volume":"25","author":"Li","year":"2016","journal-title":"J. Drug Target."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37746","DOI":"10.1021\/acsami.1c12675","article-title":"Near-Infrared Radiation-Assisted Drug Delivery Nanoplatform to Realize Blood\u2013Brain Barrier Crossing and Protection for Parkinsonian Therapy","volume":"13","author":"Liu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Cunha, A., Gaubert, A., Latxague, L., and Dehay, B. (2021). PLGA-Based nanoparticles for neuroprotective drug delivery in neuro-degenerative diseases. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13071042"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1021\/acsbiomaterials.1c00514","article-title":"Lipid-coated MCM-41 mMesoporous silica nanoparticles loaded with berberine improved inhibition of acetylcholine esterase and amyloid formation","volume":"7","author":"Singh","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.xphs.2018.06.011","article-title":"Redox- and pH-responsive nanoparticles release piperlongumine in a stimuli-sensitive manner to inhibit pulmonary metastasis of colorectal carcinoma cells","volume":"107","author":"Lee","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Song, J., Kook, M.-S., Kim, B.-H., Jeong, Y.-I., and Oh, K.-J. (2021). Ciprofloxacin-Releasing ROS-Sensitive Nanoparticles Composed of Poly(Ethylene Glycol)\/Poly(D,L-lactide-co-glycolide) for Antibacterial Treatment. Materials, 14.","DOI":"10.3390\/ma14154125"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0340-7","article-title":"ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood\u2013brain barrier","volume":"16","author":"Shen","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"119292","DOI":"10.1016\/j.biomaterials.2019.119292","article-title":"Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases","volume":"217","author":"Ballance","year":"2019","journal-title":"Biomaterials"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10611860108997929","article-title":"Interaction of poly(butylcyanoacrylate) nano-particles with the blood-brain barrier in vivo and in vitro","volume":"9","author":"Alyaudtin","year":"2001","journal-title":"J. Drug Target."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/jphp.12481","article-title":"Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats","volume":"67","author":"Sun","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"18837","DOI":"10.1073\/pnas.1111405108","article-title":"Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging","volume":"108","author":"Koffie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2008.03.007","article-title":"Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26","volume":"128","author":"Pang","year":"2008","journal-title":"J. Control. Release"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/107175400266759","article-title":"Modulating Blood-Brain Barrier Interactions of Amino Acid-Based Anticancer Agents","volume":"7","author":"Killian","year":"2000","journal-title":"Drug Deliv."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1471-4159.2001.00031.x","article-title":"A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino-acid-containing anticancer agents","volume":"76","author":"Killian","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Florendo, M., Figacz, A., Srinageshwar, B., Sharma, A., Swanson, D., Dunbar, G.L., and Rossignol, J. (2018). Use of Polyamidoamine Dendrimers in Brain Diseases. Molecules, 23.","DOI":"10.3390\/molecules23092238"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.2147\/IJN.S243155","article-title":"PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review","volume":"15","author":"Fana","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Pereira, P., Barreira, M., Cruz, C., Tom\u00e1s, J., Lu\u00eds, \u00c2., Pedro, A.Q., Queiroz, J.A., and Sousa, F. (2020). Brain-targeted delivery of pre-miR-29b using lactoferrin-stearic acid-modified-chitosan\/polyethyleneimine polyplexes. Pharmaceuticals, 13.","DOI":"10.3390\/ph13100314"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-018-0356-z","article-title":"Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: In vitro and in vivo characterization","volume":"16","author":"Ettcheto","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbagen.2014.11.006","article-title":"Neuroprotection by Kukoamine A against oxidative stress may involve N-methyl-d-aspartate receptors","volume":"1850","author":"Hu","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/01616412.2016.1245030","article-title":"Pretreatment of MQA, a caffeoylquinic acid derivative compound, protects against H2O2-induced oxidative stress in SH-SY5Y cells","volume":"38","author":"Tian","year":"2016","journal-title":"Neurol. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2019.07.011","article-title":"Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-\u03b2 peptide in Alzheimer\u2019s disease","volume":"180","author":"Rosini","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Park, J.S., Choi, H.-I., Kim, D.-H., Kim, C.S., Bae, E.H., Ma, S.K., and Kim, S.W. (2019). RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src\/Smad Signaling in HK-2 and NRK49F Cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215489"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12309\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:30:15Z","timestamp":1760167815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":54,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222212309"],"URL":"https:\/\/doi.org\/10.3390\/ijms222212309","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]}}}